Tue, May 28, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 15, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 14, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 29, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
Tue, June 27, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 16, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 28, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 17, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 21, 2023
[ 12:00 AM ] - WOPRAI
Thu, September 8, 2022
[ 12:00 AM ] - WOPRAI
Tue, June 30, 2020
[ 12:00 AM ] - WOPRAI
Thu, April 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 7, 2019
[ 12:00 AM ] - WOPRAI
Wed, August 8, 2018
[ 12:00 AM ] - WOPRAI
Fri, May 25, 2018
[ 12:00 AM ] - WOPRAI
Wed, November 8, 2017
Tue, September 19, 2017
Tue, December 6, 2016
[ 12:00 AM ] - WOPRAI
Fri, August 5, 2016
[ 12:00 AM ] - WOPRAI
Thu, June 18, 2015
[ 12:00 AM ] - WOPRAI
Fri, March 14, 2014
[ 12:00 AM ] - WOPRAI
Tue, March 4, 2014
[ 12:00 AM ] - WOPRAI
Tue, February 25, 2014
Annabel Samimy Downgraded (CALT) to Hold and Decreased Target to $40 on, May 28th, 2024
Annabel Samimy of Stifel, Downgraded "Calliditas Therapeutics AB (publ)" (CALT) to Hold and Decreased Target from $55 to $40 on, May 28th, 2024.
Annabel, nor any peers, have made any analyst calls on CALT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources